Cutaneous leukocytoclastic vasculitis associated with letrozole

Antonia Digklia; Evangelia Tzika; Ioannis A Voutsadakis

doi:10.1177/1078155213480535

Back

Cutaneous leukocytoclastic vasculitis associated with letrozole

Journal article

Peer reviewed

Cutaneous leukocytoclastic vasculitis associated with letrozole

Antonia Digklia, Evangelia Tzika and Ioannis A Voutsadakis

Journal of oncology pharmacy practice, Vol.20(2), pp.146-148

04/2014

DOI: 10.1177/1078155213480535

PMID: 23676512

View Online

Abstract

Aromatase inhibitors are increasingly used in the treatment of early and metastatic breast cancer. They can produce various skin adverse effects but are only rarely associated with cutaneous vasculitis. We report the first case of cutaneous vasculitis clearly associated with the use of aromatase inhibitor letrozole.

Aged

Antineoplastic Agents - adverse effects

Antineoplastic Agents - therapeutic use

Aromatase Inhibitors - adverse effects

Aromatase Inhibitors - therapeutic use

Breast Neoplasms - drug therapy

Female

Humans

Nitriles - adverse effects

Nitriles - therapeutic use

Triazoles - adverse effects

Triazoles - therapeutic use

Vasculitis, Leukocytoclastic, Cutaneous - chemically induced

Details

Title: Subtitle: Cutaneous leukocytoclastic vasculitis associated with letrozole
Creators: Antonia Digklia - Centre Pluridisciplinaire d'Oncologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Evangelia Tzika
Ioannis A Voutsadakis
Resource Type: Journal article
Publication Details: Journal of oncology pharmacy practice, Vol.20(2), pp.146-148
DOI: 10.1177/1078155213480535
PMID: 23676512
ISSN: 1078-1552
eISSN: 1477-092X
Language: English
Date published: 04/2014
Academic Unit: Internal Medicine
Record Identifier: 9984806613302771

Metrics

2 Record Views